Dr Reddys Laboratories Ltd.
BSE: 500124 | Sector: Health care |
NSE: DRREDDY | ISIN Code: INE089A01023 |
BSE 09:48 | 27 May | 4330.25 |
23.00 (0.53%) |
OPEN
4291.00 |
HIGH
4340.00 |
LOW
4270.20 |
NSE 09:34 | 27 May | 4285.40 |
-18.75 (-0.44%) |
OPEN
4320.00 |
HIGH
4342.40 |
LOW
4268.95 |
OPEN | 4291.00 |
PREVIOUS CLOSE | 4307.25 |
VOLUME | 2656 |
52-Week high | 5613.65 |
52-Week low | 3655.00 |
P/E | 44.40 |
Mkt Cap.(Rs cr) | 72,064 |
Buy Price | 4328.50 |
Buy Qty | 13.00 |
Sell Price | 4332.30 |
Sell Qty | 6.00 |
Dr Reddys Laboratories Ltd. (DRREDDY) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Aurobindo Pharma | 540.60 | 5.10 | 0.95 | 3112.91 |
Cipla | 968.45 | 4.05 | 0.42 | 2468.28 |
Dr Reddy's Labs | 4330.25 | 23.00 | 0.53 | 2186.40 |
Sun Pharma.Inds. | 902.95 | 2.40 | 0.27 | 2139.70 |
Divi's Lab. | 3503.80 | 54.65 | 1.58 | 1954.72 |
Alkem Lab | 3033.50 | 9.15 | 0.30 | 1685.08 |
Glenmark Pharma. | 399.50 | 5.90 | 1.50 | 1649.45 |
Zydus Lifesci. | 372.30 | -0.55 | -0.15 | 1476.20 |
Lupin | 604.25 | 3.50 | 0.58 | 1258.62 |
Alembic Pharma | 740.80 | 2.15 | 0.29 | 1175.39 |
Ipca Labs. | 912.75 | -4.40 | -0.48 | 1140.77 |
Torrent Pharma. | 2891.90 | -9.00 | -0.31 | 1137.85 |
Gland Pharma | 2878.00 | 24.75 | 0.87 | 997.01 |
Laurus Labs | 565.90 | 6.70 | 1.20 | 956.11 |
Sanofi India | 6578.35 | 43.55 | 0.67 | 944.40 |
Abbott India | 17660.20 | -38.65 | -0.22 | 690.69 |
Ajanta Pharma | 1753.10 | 24.80 | 1.43 | 675.64 |
Wockhardt | 270.50 | 7.55 | 2.87 | 593.29 |
Granules India | 272.80 | 14.20 | 5.49 | 552.78 |
Pfizer | 4256.35 | 8.40 | 0.20 | 497.61 |
Quick Links for Dr Reddys Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices